Chemico-Biological Interactions 2010-01-05

Comparative study of the oxidation of propranolol enantiomers in hepatic and small intestinal microsomes from cynomolgus and marmoset monkeys.

Takeshi Shimizudani, Kenjiro Nagaoka, Nobumitsu Hanioka, Shigeru Yamano, Shizuo Narimatsu

Index: Chem. Biol. Interact. 183(1) , 67-78, (2010)

Full Text: HTML

Abstract

Oxidative metabolism of propranolol (PL) enantiomers (R-PL and S-PL) to 4-hydroxypropranolol (4-OH-PL), 5-OH-PL and N-deisopropylpropranolol (NDP) was examined in hepatic microsomes from cynomolgus and marmoset monkeys and in small intestinal microsomes from monkeys and humans. In hepatic microsomes, levels of oxidation activities were similar between the two monkey species, and substrate enantioselectivity (R-PLS-PL) was seen in the formation of NDP in cynomolgus monkeys and humans and in the formation of 5-OH-PL in marmosets. The formation of the three metabolites in cynomolgus monkeys and the formation of NDP in marmosets were biphasic, while the formation of 4-OH-PL in humans was monophasic. From the inhibition experiments using CYP antibodies, CYP2C9 and 2C19 were thought to be involved as N-deisopropylases and CYP2D6 and 3A4 as 4-hydroxylases in human small intestine. Furthermore, CYP1A, 2C and 3A enzymes could be involved in cynomolgus monkeys and CYP2C and 3A enzymes in marmosets. These results indicate that the oxidative profile of PL in hepatic and small intestinal microsomes differ considerably among cynomolgus monkeys, marmosets and humans.


Related Compounds

Related Articles:

Stereoselective high-performance liquid chromatography determination of propranolol and 4-hydroxypropranolol in human plasma after pre-column derivatization.

1997-04-25

[J. Chromatogr. B. Biomed. Sci. Appl. 692(1) , 133-40, (1997)]

Potential bias and mitigations when using stable isotope labeled parent drug as internal standard for LC–MS/MS quantitation of metabolites

2010-01-01

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 878(31) , 3267-76, (2010)]

Potent antioxidant properties of 4-hydroxyl-propranolol.

2004-01-01

[J. Pharmacol. Exp. Ther. 308(1) , 85-90, (2004)]

Hep G2 cell line as a human model for sulphate conjugation of drugs.

1992-08-01

[Xenobiotica 22(8) , 973-82, (1992)]

Involvement of SULT1A3 in elevated sulfation of 4-hydroxypropranolol in Hep G2 cells pretreated with beta-naphthoflavone.

2005-03-15

[Biochem. Pharmacol. 69(6) , 941-50, (2005)]

More Articles...